Within Yorkshire Neville is responsible for supporting the adoption and spread of high-quality innovation that benefits patients and drives efficiencies in the NHS. Nationally. He is currently an NIHR reviewer and is a board member of the NHS National innovation Accelerator and is currently Vice Chair of the SBRI cancer panel.

Neville has previously been Chair of the AHSN Clinical Directors Forum and is involved in the AHSN network strategy development and has played a leading role in developing and publishing the networks position on real world evaluation, working closely with NICE, ABHI and the ABPI on this subject. He also supports UK businesses who wish to export and works closely with Department of International Trade (DIT) and the regional Mayoral Combined Authorities and Local Councils to attract investment into the region from a variety of international territories.

Neville has worked as an academic researcher, a drug trial manager, a consultant, as a director for a health tech start up and is focused on helping to identify and support the “pull" from the healthcare systems for innovative health technologies.

He completed his doctorate in Molecular Embryology from Kings College London, before working at the Institute of Cancer Research in London and then the Institute of Molecular Bio-Sciences in Queensland, Australia before returning to the UK and working in research development, Healthtech innovation and the AHSN network.